Straumann BLX implant: First human case study yields positive results for molar replacement
BASEL, Switzerland: Straumann is pleased to report the very positive results of the first human case study to track the condition and progress of a patient treated for a missing molar with the new Straumann BLX implant. Straumann BLX is a next-generation implant system that combines an innovative design for optimised stability with the company’s high-performance Roxolid metal alloy and SLActive surface and that offers new levels of confidence—for immediacy and beyond. Additionally, the improved usability in immediate protocols and simplified surgical and prosthetic workflows translate into higher treatment efficiency and shorter chair time for the patient.
Dr Eirik Aasland Salvesen, a periodontist at Oris Dental in Stavanger in Norway and executive director of the Oris Dental Academy, was the treating surgeon. One year ago, he placed a Straumann BLX implant into a healed mandibular first molar site and restored the implant prosthetically through an analogue workflow in the temporary phase and digital workflow for the final restoration.
The patient, a 67-year-old non-smoking man without any relevant medical history, was referred to the office with a missing tooth (#36) due to persistent apical periodontitis. The tooth had been extracted more than one year prior to the procedure and the molar site was well maintained and fully healed (Fig. 1). A CBCT scan showed that the patient had favourable bone availability (Fig. 2), on which basis a one-stage placement of a 5.5 × 10.0 mm Straumann BLX implant was planned. After surgically installing the implant (Figs. 3–7), Salvesen allowed the surrounding soft tissue to mature and heal for six weeks (Fig. 8). He then removed the healing abutment to begin the prosthetic procedures for a temporary crown (Figs. 9 & 10). A stone master cast was made in the laboratory, and a temporary screw-retained PMMA crown was manufactured over a Straumann wide base temporary abutment for the crown (Fig. 11) and placed on to the implant (Figs. 12–14).
After 12 weeks, Salvesen removed the temporary crown, revealing that the soft tissue had healed very well (Fig. 15). He then began the digital workflow. For the final crown, a digital impression was taken with a 3Shape intra-oral scanner, using a Straumann CARES scan body. A monolithic zirconia crown was then seated passively on to the implant in a healed and preconditioned soft-tissue environment (Figs. 16–19).
One year after the treatment, the patient reports complete satisfaction with both his chewing function and the overall aesthetics (Figs. 20 & 21). Radiographs confirm that the molar site is stable and healthy (Fig. 22). In this first human case, use of the Straumann BLX wide base implant delivered efficient and reliable performance, even in soft bone with early loading conditions.
The risks of previous routine treatments
For many years, conventional fixed bridges were considered routine treatment for replacing a missing single tooth, according to periodontist and oral surgeon Dr Christian Rado Jarry of Straumann’s Global Medical Affairs Department in Basel. “However,” Jarry noted, “this treatment increased the risk of iatrogenic endodontic damage during the invasive preparation of otherwise healthy, undisturbed teeth, which decreased the survival of these teeth over time.”
The use and success of dental implants for rehabilitating the partially edentulous posterior jaw is well established. In addition to its high success rate, it leaves the adjacent teeth undisturbed. That said, Jarry added, successful use of dental implants depends on optimal conditions of the peri-implant tissue. To determine implant dimensions, one must first do a 3-D evaluation of the patient’s bone condition and availability, a key step for the long-term stability of hard and soft tissue.
About single molar restorations
The success of single molar restorations is influenced by factors such as the clinician’s skills, arch morphology, proximity of adjacent teeth, vertical access, anatomy and patient-related limitations. Salvesen noted that the use of wide implants has been proposed as a successful option, with survival rates similar to those of standard-diameter implants.
While osseointegration remains the basis for success, patients’ increasing expectations add new requirements to the definition of success and failure. From a patient’s perspective, success may be defined by not only how functional and natural the outcome is, but also if the treatment required fewer visits to the clinic.
“Clinicians increasingly are using CAD/CAM materials and chairside systems, as well as digital workflows, especially for single-unit restorations. This has been shown to allow for cost-effective and efficient treatment protocols that improve patient satisfaction,” added Jarry.
An enthusiastic response from clinicians
In total, more than 100 clinicians have been working with BLX and have documented their results. A non-interventional multicentre clinical study, currently running, specifically details the new implant’s performance in the everyday practice setting.
“The related feedback is extremely positive,” said Dr George Raeber, Head of Global Product Management for the Straumann Dental Implant System. “An impressive amount of clinical data is already available as we begin to commercialise Straumann’s BLX. We sometimes prefer to go to market a little bit later, but with a rock-solid proposal.”
“When I work with immediacy,” said Salvesen, “I want products that provide me with peace of mind in demanding clinical situations. Straumann BLX implants with Roxolid and SLActive give me that confidence. BLX is exciting because it extends the treatment options we can offer with Straumann products. It’s a new era of implant treatment.”
Editorial note: The case study, titled “Pristine function and aesthetics: One-year follow-up of molar replacement with a new fully tapered implant system”, was published in Issue 1/19 of EDI Journal.